{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T04:50:14Z","timestamp":1762145414775,"version":"3.41.2"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Funds for Statutory Activity of Medical University of Lublin, Poland"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacological Reports"],"published-print":{"date-parts":[[2019,8]]},"DOI":"10.1016\/j.pharep.2019.03.007","type":"journal-article","created":{"date-parts":[[2019,3,16]],"date-time":"2019-03-16T20:37:46Z","timestamp":1552768666000},"page":"676-681","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["Agomelatine and tianeptine antidepressant activity in mice behavioral despair tests is enhanced by DMPX, a selective adenosine A2A receptor antagonist, but not DPCPX, a selective adenosine A1 receptor antagonist"],"prefix":"10.1007","volume":"71","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7756-2904","authenticated-orcid":false,"given":"Aleksandra","family":"Szopa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karolina","family":"Bogatko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Serefko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"El\u017cbieta","family":"Wyska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sylwia","family":"Wo\u015bko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katarzyna","family":"\u015awi\u0105der","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Urszula","family":"Doboszewska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aleksandra","family":"Wla\u017a","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5772-0573","authenticated-orcid":false,"given":"Andrzej","family":"Wr\u00f3bel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Piotr","family":"Wla\u017a","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jaros\u0142aw","family":"Dudka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ewa","family":"Poleszak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"10.1016\/j.pharep.2019.03.007_bib0005","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1056\/NEJMra073096","article-title":"Major depressive disorder","volume":"358","author":"Belmaker","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.pharep.2019.03.007_bib0010","doi-asserted-by":"crossref","first-page":"51","DOI":"10.2147\/nedt.1.1.51.52298","article-title":"What moderator characteristics are associated with better prognosis for depression?","volume":"1","author":"Trivedi","year":"2005","journal-title":"Neuropsychiatr Dis Treat"},{"key":"10.1016\/j.pharep.2019.03.007_bib0015","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1001\/jama.2009.1943","article-title":"Antidepressant drug effects and depression severity: a patient-level meta-analysis","volume":"303","author":"Fournier","year":"2010","journal-title":"JAMA"},{"key":"10.1016\/j.pharep.2019.03.007_bib0020","doi-asserted-by":"crossref","first-page":"e45","DOI":"10.1371\/journal.pmed.0050045","article-title":"Initial severity and antidepressant benefits: a meta-analysis of data submitted to the Food and Drug Administration","volume":"5","author":"Kirsch","year":"2008","journal-title":"PLoS Med"},{"issue":"1","key":"10.1016\/j.pharep.2019.03.007_bib0025","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1038\/sj.bjp.0704240","article-title":"Adenosine A2A receptor antagonista are potential antidepressants: evidence based on pharmacology and A2A receptor knockout mice","volume":"134","author":"El Yacoubi","year":"2001","journal-title":"Br J Pharmacol"},{"issue":"11 Suppl 6","key":"10.1016\/j.pharep.2019.03.007_bib0030","doi-asserted-by":"crossref","first-page":"S82","DOI":"10.1212\/01.WNL.0000095220.87550.F6","article-title":"Adenosine A2A receptors and depression","volume":"61","author":"El Yacoubi","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.pharep.2019.03.007_bib0035","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1007\/PL00005326","article-title":"Comparison of CGS 15943, ZM 241385 and SCH 58261 as antagonists at human adenosine receptors","volume":"359","author":"Ongini","year":"1999","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"10.1016\/j.pharep.2019.03.007_bib0040","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1007\/s00210-015-1189-z","article-title":"Caffeine enhances the antidepressant-like activity of common antidepressant drugs in the forced swim test in mice. Naunyn Schmiedebergs","volume":"389","author":"Szopa","year":"2016","journal-title":"Arch Pharmacol"},{"key":"10.1016\/j.pharep.2019.03.007_bib0045","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.pbb.2013.10.022","article-title":"Antidepressant-like activity of the adenosine A(2A) receptor antagonist istradefylline (KW-6002), in the forced swim test and the tail suspension test in rodents","volume":"114\u2013115","author":"Yamada","year":"2013","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.pharep.2019.03.007_bib0050","first-page":"527","article-title":"International Union of Pharmacology. XXV. Nomenclature and classification of adenosine receptors","volume":"53","author":"Fredholm","year":"2001","journal-title":"Pharmacol Rev"},{"issue":"193","key":"10.1016\/j.pharep.2019.03.007_bib0055","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1007\/978-3-540-89615-9_16","article-title":"Adenosine receptors and the central nervous system","author":"Sebasti\u00e3o","year":"2009","journal-title":"Handb Exp Pharmacol"},{"key":"10.1016\/j.pharep.2019.03.007_bib0060","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.pharep.2015.06.138","article-title":"Caffeine augments the antidepressant-like activity of mianserin and agomelatine in forced swim and tail suspension tests in mice","volume":"68","author":"Poleszak","year":"2016","journal-title":"Pharmacol Rep"},{"issue":"15","key":"10.1016\/j.pharep.2019.03.007_bib0065","doi-asserted-by":"crossref","first-page":"3604","DOI":"10.1111\/bph.12720","article-title":"Agomelatine: mechanism of action and pharmacological profile in relation to antidepressant properties","volume":"171","author":"Guardiola-Lemaitre","year":"2014","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.pharep.2019.03.007_bib0070","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/B978-0-12-801022-8.00015-5","article-title":"Involvement of adenosine A2A receptors in depression and anxiety","volume":"119","author":"Yamada","year":"2014","journal-title":"Int Rev Neurobiol"},{"issue":"9","key":"10.1016\/j.pharep.2019.03.007_bib0075","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1111\/jphp.12954","article-title":"The influence of selective A1 and A2A receptor antagonists on the antidepressant-like activity of moclobemide, venlafaxine and bupropion in mice","volume":"70","author":"Bogatko","year":"2018","journal-title":"J Pharm Pharmacol"},{"key":"10.1016\/j.pharep.2019.03.007_bib0080","first-page":"327","article-title":"Behavioral despair in mice: a primary screening test for antidepressants","volume":"229","author":"Porsolt","year":"1977","journal-title":"Arch Int Pharmacodyn Ther"},{"key":"10.1016\/j.pharep.2019.03.007_bib0085","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1007\/BF00428203","article-title":"The tail suspension test: a new method for screening antidepressants in mice","volume":"85","author":"Steru","year":"1985","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.pharep.2019.03.007_bib0090","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1016\/j.pharep.2016.04.013","article-title":"Traxoprodil augments the antidepressant-like activity of agomelatine but not of mianserin or tianeptine in the forced swim test in mice","volume":"68","author":"Stasiuk","year":"2016","journal-title":"Pharmacol Rep"},{"issue":"7","key":"10.1016\/j.pharep.2019.03.007_bib0095","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1038\/sj.bjp.0703170","article-title":"The stimulant effects of caffeine on locomotor behaviour in mice are mediated through its blockade of adenosine A(2A) receptors","volume":"129","author":"El Yacoubi","year":"2000","journal-title":"Br J Pharmacol"},{"issue":"4","key":"10.1016\/j.pharep.2019.03.007_bib0100","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1007\/BF00429665","article-title":"Purine nucleoside-mediated immobility in mice: reversal by antidepressants","volume":"85","author":"Kulkarni","year":"1985","journal-title":"Psychopharmacology (Berl)"},{"issue":"2","key":"10.1016\/j.pharep.2019.03.007_bib0105","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1037\/0735-7044.112.2.399","article-title":"Inhibition of adenosine deaminase by erythro-9-(2-hydroxy-3-nonyl)adenine (EHNA) mimics the effect of inescapable shock on escape learning in rats","volume":"112","author":"Woodson","year":"1998","journal-title":"Behav Neurosci"},{"key":"10.1016\/j.pharep.2019.03.007_bib0110","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.neulet.2003.10.040","article-title":"Adenosine administration produces an antidepressant-like effect in mice: evidence for the involvement of A1 and A2A receptors","volume":"355","author":"Kaster","year":"2004","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.pharep.2019.03.007_bib0115","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.bbr.2015.02.032","article-title":"Adenosine signaling in reserpine-induced depression in rats","volume":"286","author":"Minor","year":"2015","journal-title":"Behav Brain Res"},{"key":"10.1016\/j.pharep.2019.03.007_bib0120","article-title":"Antidepressant-like activity of typical antidepressant drugs in the forced swim test and tail suspension test in mice is augmented by DMPX, an adenosine A2A receptor antagonist","author":"Poleszak","year":"2018","journal-title":"Neurotox Res"},{"key":"10.1016\/j.pharep.2019.03.007_bib0125","doi-asserted-by":"crossref","DOI":"10.1007\/s00210-018-1551-z","article-title":"DPCPX, a selective adenosine A1 receptor antagonist, enhances the antidepressant-like effects of imipramine, escitalopram, and reboxetine in mice behavioral tests","author":"Szopa","year":"2018","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"10.1016\/j.pharep.2019.03.007_bib0130","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1017\/S1461145705005316","article-title":"Involvement of nitric oxide-cGMP pathway in the antidepressant-like effects of adenosine in the forced swimming test","volume":"8","author":"Kaster","year":"2005","journal-title":"Int J Neuropsychopharmacol"},{"key":"10.1016\/j.pharep.2019.03.007_bib0135","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.brainresbull.2005.05.025","article-title":"Involvement of 5-HT1A receptors in the antidepressant-like effect of adenosine in the mouse forced swimming test","volume":"67","author":"Kaster","year":"2005","journal-title":"Brain Res Bull"},{"key":"10.1016\/j.pharep.2019.03.007_bib0140","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.ejphar.2007.08.026","article-title":"Pharmacological evidence for the involvement of the opioid system in the antidepressant-like effect of adenosine in the mouse forced swimming test","volume":"576","author":"Kaster","year":"2007","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pharep.2019.03.007_bib0145","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1038\/mp.2009.80","article-title":"The neurobiological properties of tianeptine (Stablon): from monoamine hypothesis to glutamatergic modulation","volume":"15","author":"McEwen","year":"2010","journal-title":"Mol Psychiatry"},{"issue":"2","key":"10.1016\/j.pharep.2019.03.007_bib0150","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/s00210-007-0135-0","article-title":"Characterization of the potency, selectivity, and pharmacokinetic profile for six adenosine A2A receptor antagonists","volume":"375","author":"Yang","year":"2007","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"issue":"1","key":"10.1016\/j.pharep.2019.03.007_bib0155","doi-asserted-by":"crossref","first-page":"35","DOI":"10.9740\/mhc.2016.01.035","article-title":"A review of significant pharmacokinetic drug interactions with antidepressants and their management","volume":"6","author":"Hoffelt","year":"2016","journal-title":"Ment Health Clin"}],"container-title":["Pharmacological Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S173411401830611X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S173411401830611X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,15]],"date-time":"2025-07-15T20:37:58Z","timestamp":1752611878000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1016\/j.pharep.2019.03.007"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8]]},"references-count":31,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019,8]]}},"alternative-id":["S173411401830611X"],"URL":"https:\/\/doi.org\/10.1016\/j.pharep.2019.03.007","relation":{},"ISSN":["1734-1140"],"issn-type":[{"type":"print","value":"1734-1140"}],"subject":[],"published":{"date-parts":[[2019,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Agomelatine and tianeptine antidepressant activity in mice behavioral despair tests is enhanced by DMPX, a selective adenosine A2A receptor antagonist, but not DPCPX, a selective adenosine A1 receptor antagonist","name":"articletitle","label":"Article Title"},{"value":"Pharmacological Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pharep.2019.03.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Institute of Pharmacology, Polish Academy of Sciences. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}